The originating document has been archived. We cannot confirm the completeness, accuracy, or currency of the content.

Canine Spectra Parvo

This page contains information on Canine Spectra Parvo for veterinary use.
The information provided typically includes the following:

Canine Spectra Parvo Indications
Warnings and cautions for Canine Spectra Parvo
Direction and dosage information for Canine Spectra Parvo

Canine Spectra Parvo

This treatment applies to the following species:

Dogs

Manufacturer: Durvet

Parvovirus Vaccine

MODIFIED LIVE VIRUS

Product Description

CANINE SPECTRA™ PARVO vaccine is a modified live virus vaccine containing a CPV Type 2b strain for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine parvovirus.

Canine Spectra Parvo Dosage And Administration

Inject one dose (1 mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. Annual revaccination with one dose is recommended. Use entire contents immediately.

Step 1. Withdraw mixture into syringe.

Step 2. To administer subcutaneously, gently grasp and elevate a fold of loose skin.

Step 3. Insert the needle into the loose tissue under the skin. Suggested vaccination site - under loose skin (back of neck).

Precautions

Store at 35°-45°F (2°-7°C). Do not freeze. Use new, non-chemically sterilized, needles and syringes. Do not mix with other vaccines. Burn vaccine containers and all unused contents.

Warnings

Vaccinate only healthy, non-parasitized dogs. Do not vaccinate pregnant bitches. Contains gentamicin as a preservative. The use of this biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.

Antidote

Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction. The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch's titer and quantity of colostral antibodies absorbed by the puppy.

For veterinary use only. For use in dogs only.

Produced by: Schering-Plough Animal Health Corp., Omaha, NE 68103 USA

U.S. Vet. License No. 165A

Distributed by: Peak Marketing, P.O. Box 279, Blue Springs, MO 64013 USA

1 800 821-5570

	NDC
1 Dose/1mL	0061-1524-04	P00100-11

Nac No.

10842450

DURVET, INC.
P.O. BOX 279, 100 S.E. MAGELLAN DRIVE, BLUE SPRINGS, MO, 64014

Telephone:		816-229-9101
Order Desk:		800-821-5570
Fax:		816-224-3080
Website:		www.durvet.com
Email:		info@durvet.com

Every effort has been made to ensure the accuracy of the Canine Spectra Parvo information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canine Spectra Parvo product label or package insert.